Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.

Bartłomiej KisielRobert KruszewskiAleksandra JuszkiewiczAnna RaczkiewiczArtur BachtaMałgorzata TłustochowiczJadwiga Staniszewska-VargaKrzysztof KłosKrzysztof DudaRomana Bogusławska-WaleckaRafał PłoskiWitold Tłustochowicz

Published in: Journal of immunology research (2015)

We found a beneficial effect of MTX ≥ 20 mg/wk, biologics, and CsA on atherosclerosis. We do not confirm a stronger influence of biologics on IMT compared with therapeutic doses of MTX.

Keyphrases

rheumatoid arthritis
cardiovascular disease
high dose
disease activity
type diabetes
interstitial lung disease
low dose
systemic lupus erythematosus
systemic sclerosis